INEGY

This brand name is authorized in Austria, Croatia, Cyprus, France, Germany, Ireland, Italy, Netherlands, Poland, South Africa, Spain, UK.

Active ingredients

The drug INEGY contains a combination of these active pharmaceutical ingredients (APIs):

1	Ezetimibe UNII EOR26LQQ24 - EZETIMIBE
	Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol.
	Read more about Ezetimibe
2	Simvastatin UNII AGG2FN16EV - SIMVASTATIN
	Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations.
	Read more about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INEGY Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10BA02	Simvastatin and ezetimibe	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00140296, 00760946, 00760975, 00761029, 00761041, 00761064, 00761093, 00761118, 00761130, 05374136, 06766648, 06766677, 06766714, 07495393, 07758881, 07758906, 07758912, 07758958, 09607092, 09607100, 09649328, 09887335, 09887341, 09887358, 10135592, 10218450, 10263746, 10554751, 11022370, 11111151, 11111168, 11229450, 11282964, 11522316, 11522322, 11522339, 11522345, 11522351, 11522368, 11689944, 11689950, 11711201, 11711218, 11714145, 11714151, 12405311, 13845911, 14418217, 14418223, 14418513, 15293315, 15293321, 16735815, 16812243, 16812266, 17242440, 17242457, 17258346
ES	Centro de información online de medicamentos de la AEMPS	66513, 66514, PA1286-062
FR	Base de données publique des médicaments	60061709, 60371679, 61238347, 63857227, 65057814, 65722573
GB	Medicines & Healthcare Products Regulatory Agency	398364, 93100, 93104, 93108
HR	Agencija za lijekove i medicinske proizvode	HR-H-251011951, HR-H-435536175, HR-H-814412843
IE	Health Products Regulatory Authority	19562, 19635, 29803, 29845, 29869, 29876
IT	Agenzia del Farmaco	036679064, 036679215, 036679367
NL	Z-Index G-Standaard, PRK	77038, 77046, 77054
PL	Rejestru Produktów Leczniczych	100172614, 100172650, 100172689, 100172695
ZA	Health Products Regulatory Authority	A39/7.5/0031, A39/7.5/0032, A39/7.5/0033, A39/7.5/0034